As the first and only fractional laser ever to be FDA-cleared for home use, the PaloVia laser truly is a breakthrough.
Burlington, MA (PRWEB) September 20, 2011
For 15 years, the Allure Best of Beauty seal has been recognized as a premier award in the beauty industry and is held in high regard by consumers. Eligible products from more than a dozen beauty categories are vigorously vetted by both Allure editors and industry experts.
The PaloVia Skin Renewing Laser underwent several rounds of intense inspection and scrutiny to stand among 14 total products receiving the “Big Breakthrough” award. “We always knew we had a revolutionary product on our hands,” said Joseph Caruso, Chief Executive Officer of Palomar Medical Technologies. “As the first and only fractional laser ever to be FDA-cleared for home use, the PaloVia laser truly is a breakthrough.”
Palomar research shows that, although women have increasingly high awareness of professional aesthetic treatments, overall usage of these treatments remains low. “Since these women are generally dissatisfied with their existing anti-aging products,” continued Mr. Caruso, “we see tremendous growth potential – especially with clinically proven treatments such as laser skin rejuvenation.” The PaloVia laser is the only FDA-cleared, at-home laser clinically proven to reduce fine lines and wrinkles around the eyes. Now that it has received the prestigious “Best of Beauty” seal from Allure magazine, more women will be aware of this at-home opportunity to achieve dramatic results, with a treatment schedule and price that work for their lifestyle.
About Palomar Medical Technologies
The PaloVia Skin Renewing Laser was developed by Palomar Medical Technologies, Inc., a leading manufacturer of cosmetic lasers for dermatologists and plastic surgeons.
For nearly two decades, Palomar has revolutionized laser skin treatment. In the 1990s, a global team of Palomar laser physicists and esteemed dermatologists began experimenting with non-ablative fractional laser treatments — a new technique that kept the outer layer of skin in place (“non-ablative”) and treated only a small portion ("fraction") of the skin with each application of light. In 2000, Palomar filed a patent application on this fractional laser technology and began selling systems to doctors for use on their patients. In 2009, after years of clinical studies, Palomar received FDA clearance for the first at-home fractional laser clinically proven to reduce fine lines and wrinkles around the eyes.
For more information about the PaloVia Skin Renewing Laser, visit palovia.com.
PaloVia Customer Care